Empagliflozin did not cut risk for death, HF hospitalization after heart attack: EMPACT-MI healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
For an all-comer population with any impairment of LV function, an interarterial shunt device missed the primary endpoint in RELIEVE-HF, but benefit was seen with LVEF less than 40%.
The Pulse of ACC: 2022 Distinguished Awardees - American College of Cardiology acc.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acc.org Daily Mail and Mail on Sunday newspapers.